查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594382

多重檢測市場：按產品/服務、類型、技術、應用、最終用戶 - 2025-2030 年全球預測

Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, Protein Multiplex Assays), Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年多重檢測市場價值為 38.9 億美元，預計到 2024 年將達到 42.1 億美元，複合年成長率為 8.50%，到 2030 年將達到 68.8 億美元。

多重檢測是一種診斷工具，可以同時檢測和定量一個樣品中的多種分析物，從而提高通量和資料準確性。對多重檢測的需求源於其簡化生物技術、藥物開發和臨床診斷工作流程的能力，並且已被證明對於個人化醫療、疾病分析和生物標記發現等應用至關重要。這些檢測方法已廣泛應用於腫瘤學、自體免疫疾病、感染疾病和過敏測試等領域。主要成長動力包括慢性病盛行率的增加、對就地檢驗的需求以及蛋白質體學和基因組學的進步。技術的進步、伴同性診斷的更大接受度以及生物標記識別研究的擴展也為市場擴張鋪平了道路。然而，市場面臨著高成本、嚴格的法規環境以及檢測設計和資料解釋的複雜性等限制。為了利用這個機會，建議投資自動化、創新檢測平台以及與研究和醫療機構的合作。單細胞分析和資料分析人工智慧整合等新興領域為創新提供了肥沃的土壤。該市場的特點是主要企業之間的競爭側重於技術增強和策略聯盟。研究工作可以集中於開發具有成本效益且易於使用的平台，以保持高靈敏度和特異性。為了克服挑戰並利用快速成長的商機，公司必須優先考慮研發，包括改進檢測技術、開發方便用戶使用的介面以及擴展可檢測分析物的種類。解決與現有實驗室工作流程的互通性等限制以及克服複雜生物樣品所帶來的分析挑戰至關重要。總體而言，在不斷變化的醫療需求和技術進步的支持下，多重檢測市場預計將出現強勁成長，戰略重點是業務擴展所必需的創新和協作。

主要市場統計
基準年[2023] 38.9億美元
預測年份 [2024] 42.1億美元
預測年份 [2030] 68.8億美元
複合年成長率（%） 8.50%

市場動態：揭示快速發展的多重檢測市場的關鍵市場洞察

供需的動態交互作用正在改變多重檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病和感染疾病增加，快速轉向早期診斷
    • 高度個人化藥物的使用迅速增加
    • 擴大多重測定在藥物開發的應用
  • 市場限制因素
    • 多重檢測的複雜性和設備高成本
  • 市場機會
    • 多重技術在臨床診斷上的興起
    • 在臨床環境中採用自動化設備和裝置的可能性
  • 市場問題
    • 缺乏熟練且經驗豐富的醫療專業人員

波特五力：駕馭多重檢測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解多重偵測市場的外部影響

外部宏觀環境因素在塑造多重偵測市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解多重檢測市場的競爭格局

對多重檢測市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：多重偵測市場供應商的績效評估

FPNV 定位矩陣是評估多重偵測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製多重檢測市場的成功之路

多重檢測市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和感染疾病增加，快速轉向早期診斷
      • 個人化精準醫療的使用快速成長
      • 擴大多種檢測方法在藥物開發的應用
    • 抑制因素
      • 多重測定的相關複雜性和設備的高成本
    • 機會
      • 臨床診斷中的多重檢測新技術
      • 在臨床環境中引入自動化設備和裝置的可能性
    • 任務
      • 缺乏技術精湛、經驗豐富的醫護人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章多重檢測市場：依產品與服務分類

  • 介紹
  • 消耗品
  • 裝置
  • 軟體和服務

第7章多重檢測市場：依類型

  • 介紹
  • 基於細胞的多重檢測
  • 核酸多重檢測
    • 以微珠為基礎的核酸檢測
    • 平面核酸測定
  • 蛋白質多重檢測
    • 以微珠為基礎的蛋白質檢測
    • 平面蛋白質測定

第8章多重檢測市場：依技術分類

  • 介紹
  • 流式細胞技術
  • 螢光偵測
  • 發光
  • 多重即時流式細胞技術
  • 多重即時PCR

第9章多重檢測市場：依應用分類

  • 介紹
  • 臨床診斷
    • 自體免疫疾病
    • 癌症
    • 心血管疾病
    • 感染疾病
    • 代謝及內分泌疾病
    • 神經系統疾病
  • 研究與開發
    • 生物標記的發現與檢驗
    • 藥物發現與開發

第 10 章多重檢測市場：依最終用戶分類

  • 介紹
  • 醫院/研究所
  • 製藥和生物技術公司
  • 參考實驗室

第11章美洲多重檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太多重檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的多重檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abcam PLC
  • Agilent Technologies, Inc.
  • Antigenix America, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cayman Chemical Company
  • Charles River Laboratories
  • Enfer Group
  • Enzo Life Sciences, Inc.
  • Eve Technologies Corp.
  • Flagship Biosciences Inc.
  • Future Diagnostics Solutions BV
  • Gnome Diagnostics and Gnome Sciences
  • Illumina, Inc.
  • Merck KGaA
  • MESO SCALE DIAGNOSTICS, LLC
  • Novatein Biosciences Inc.
  • PerkinElmer, Inc.
  • Protavio Ltd.
  • Siemens Healthineers AG
  • Solis BioDyne OU
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8201ABF20BB9

The Multiplex Assays Market was valued at USD 3.89 billion in 2023, expected to reach USD 4.21 billion in 2024, and is projected to grow at a CAGR of 8.50%, to USD 6.88 billion by 2030.

Multiplex assays are diagnostic tools that allow for the simultaneous detection and quantification of multiple analytes in a single sample, enhancing throughput and data accuracy. The necessity of multiplex assays arises from their ability to streamline workflows in biotechnology, pharmaceutical development, and clinical diagnostics, proving essential for applications like personalized medicine, disease profiling, and biomarker discovery. These assays find extensive end-use in oncology, autoimmune diseases, infectious diseases, and allergy testing, among others. Key growth drivers include the increasing prevalence of chronic diseases, the demand for point-of-care testing, and advances in proteomics and genomics. Technological advancements, growing acceptance of companion diagnostics, and expanding research in biomarker identification further pave the way for market expansion. Nevertheless, the market faces constraints such as high costs, stringent regulatory environments, and the complexity of assay design and data interpretation. To capitalize on opportunities, investments in automation, innovative assay platforms, and partnerships with research and healthcare institutions are recommended. Emerging niches like single-cell analysis and the integration of artificial intelligence for data analysis offer fertile ground for innovation. The market is characterized by competition among key players focusing on technological enhancements and strategic collaborations. Research efforts can be concentrated on developing cost-effective, easy-to-use platforms that maintain high sensitivity and specificity. To overcome challenges and tap into burgeoning opportunities, companies must prioritize research and development to refine assay technologies, foster user-friendly interfaces, and expand the repertoire of detectable analytes. Addressing limitations like interoperability with existing laboratory workflows and overcoming the analytical challenges posed by complex biological samples will be crucial. Overall, the market for multiplex assays is poised for robust growth, underpinned by evolving healthcare needs and technological progress, with a strategic emphasis on innovation and collaboration essential for business expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 3.89 billion
Estimated Year [2024] USD 4.21 billion
Forecast Year [2030] USD 6.88 billion
CAGR (%) 8.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiplex Assays Market

The Multiplex Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising chronic and infectious disease and rapid shift towards early diagnosis
    • Surge in usage of personalized-precision medications
    • Growing application of multiple assays in drug development
  • Market Restraints
    • Associated shear complexity of multiplex assays and high cost of instruments
  • Market Opportunities
    • Emerging technology of multiplexing in clinical diagnostics
    • Potential adoption of automated instruments and equipment in clinical practice
  • Market Challenges
    • Shortage of skilled and experienced healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Multiplex Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiplex Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiplex Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiplex Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiplex Assays Market

A detailed market share analysis in the Multiplex Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiplex Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiplex Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiplex Assays Market

A strategic analysis of the Multiplex Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Antigenix America, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cayman Chemical Company, Charles River Laboratories, Enfer Group, Enzo Life Sciences, Inc., Eve Technologies Corp., Flagship Biosciences Inc., Future Diagnostics Solutions B.V., Gnome Diagnostics and Gnome Sciences, Illumina, Inc., Merck KGaA, MESO SCALE DIAGNOSTICS, LLC, Novatein Biosciences Inc., PerkinElmer, Inc., Protavio Ltd., Siemens Healthineers AG, Solis BioDyne OU, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Consumables, Instruments, and Software & Services.
  • Based on Type, market is studied across Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, and Protein Multiplex Assays. The Nucleic Acid Multiplex Assays is further studied across Bead-Based Nucleic Acid Assays and Planar Nucleic Acid Assays. The Protein Multiplex Assays is further studied across Bead-Based Protein Assays and Planar Protein Assays.
  • Based on Technology, market is studied across Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time Flow Cytometry, and Multiplex Real-Time PCR.
  • Based on Application, market is studied across Clinical Diagnostics and Research & Development. The Clinical Diagnostics is further studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Infectious Diseases, Metabolism & Endocrinology Disorders, and Nervous System Disorders. The Research & Development is further studied across Biomarker Discovery & Validation and Drug Discovery & Development.
  • Based on End User, market is studied across Hospitals & Research Institutes, Pharmaceutical & Biotechnology Companies, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising chronic and infectious disease and rapid shift towards early diagnosis
      • 5.1.1.2. Surge in usage of personalized-precision medications
      • 5.1.1.3. Growing application of multiple assays in drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Associated shear complexity of multiplex assays and high cost of instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technology of multiplexing in clinical diagnostics
      • 5.1.3.2. Potential adoption of automated instruments and equipment in clinical practice
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled and experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Multiplex Assays Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software & Services

7. Multiplex Assays Market, by Type

  • 7.1. Introduction
  • 7.2. Cell-Based Multiplex Assays
  • 7.3. Nucleic Acid Multiplex Assays
    • 7.3.1. Bead-Based Nucleic Acid Assays
    • 7.3.2. Planar Nucleic Acid Assays
  • 7.4. Protein Multiplex Assays
    • 7.4.1. Bead-Based Protein Assays
    • 7.4.2. Planar Protein Assays

8. Multiplex Assays Market, by Technology

  • 8.1. Introduction
  • 8.2. Flow Cytometry
  • 8.3. Fluorescence Detection
  • 8.4. Luminescence
  • 8.5. Multiplex Real-Time Flow Cytometry
  • 8.6. Multiplex Real-Time PCR

9. Multiplex Assays Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
    • 9.2.1. Autoimmune Diseases
    • 9.2.2. Cancer
    • 9.2.3. Cardiovascular Diseases
    • 9.2.4. Infectious Diseases
    • 9.2.5. Metabolism & Endocrinology Disorders
    • 9.2.6. Nervous System Disorders
  • 9.3. Research & Development
    • 9.3.1. Biomarker Discovery & Validation
    • 9.3.2. Drug Discovery & Development

10. Multiplex Assays Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals & Research Institutes
  • 10.3. Pharmaceutical & Biotechnology Companies
  • 10.4. Reference Laboratories

11. Americas Multiplex Assays Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Multiplex Assays Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Multiplex Assays Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam PLC
  • 3. Agilent Technologies, Inc.
  • 4. Antigenix America, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. Cayman Chemical Company
  • 9. Charles River Laboratories
  • 10. Enfer Group
  • 11. Enzo Life Sciences, Inc.
  • 12. Eve Technologies Corp.
  • 13. Flagship Biosciences Inc.
  • 14. Future Diagnostics Solutions B.V.
  • 15. Gnome Diagnostics and Gnome Sciences
  • 16. Illumina, Inc.
  • 17. Merck KGaA
  • 18. MESO SCALE DIAGNOSTICS, LLC
  • 19. Novatein Biosciences Inc.
  • 20. PerkinElmer, Inc.
  • 21. Protavio Ltd.
  • 22. Siemens Healthineers AG
  • 23. Solis BioDyne OU
  • 24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIPLEX ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MULTIPLEX ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIPLEX ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY METABOLISM & ENDOCRINOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 201